05 Aug Date August 5, 2019 Categories GUIDELINES AND POSITION PAPERS HIGHLIGHTS, IN EVIDENCE POSITION PAPER ON THE MANAGEMENT OF IMMUNOCOMPROMISED PATIENT WITH HCV INFECTION The Position Paper AISF: “HCV in immunocompromised patients” is avaliable in Digestive and Liver Diseases. Download Document